May/June 2017

Oral cancer treatments provide new opportunities for improved overall survival rates, but patients are increasingly responsible for higher out-of-pocket costs as they self-manage their therapy.

Legendary NBA star Kareem-Abdul Jabbar faced his toughest battle after being diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia.

Specialty pharmacists are uniquely positioned to help with the treatment of breast cancer.

With the rise of oral oncolytics, the ability to educate patients while providing resources to monitor compliance and adverse-effect management becomes even more critical. 

Stakeholders are concerned a universal protocol for testing closed-system transfer devices will not adequately address different systems that protect against hazardous drugs.

The shifting landscape in specialty dispensing among pharmacies that service patients in senior care settings and long-term care facilities.

The final days of the Obama administration witnessed the federal government launch several initiatives seeking to advance the battle against cancer. 

Guidelines and tips that can help specialty pharmacies keep communications related to day-to-day operations, contract negotiation, and mergers and acquisitions privileged.

Emerging oncology therapies, often made available to patients through specialty pharmacies, continue to be a key driver and focus of the business.